Systemic inflammation, TNM staging and survival in patients with lung cancer Cover

.blurhash-client-img { display: none !important; }

Systemic inflammation, TNM staging and survival in patients with lung cancer

Volume 69 (2020): Issue 2 (December 2020)

By: Ionela Erhan, Stefan Dumitrache-Rujinski, Claudia Toma and Miron Bogdan

Open Access

|Dec 2020

Authors

Ionela Erhan

nely_erhan@yahoo.com

”Dr. Carol Davila” Central Military Emergency Universitary Hospital Bucharest, Romania

Stefan Dumitrache-Rujinski

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Marius Nasta Institute of Pulmonology, Bucharest, Romania

Claudia Toma

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Marius Nasta Institute of Pulmonology, Bucharest, Romania

Miron Bogdan

Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

Marius Nasta Institute of Pulmonology, Bucharest, Romania

DOI: https://doi.org/10.2478/pneum-2020-0016 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 81 - 86

Published on: Dec 31, 2020

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

systemic inflammation,

neutrophil-to-lymphocyte ratio,

platelet-to-lymphocyte ratio

Related subjects:

Clinical medicine,

Clinical medicine, other,

Internal medicine,

© 2020 Ionela Erhan, Stefan Dumitrache-Rujinski, Claudia Toma, Miron Bogdan, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 69 (2020): Issue 2 (December 2020)Next article